Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INTEGRA LIFESCIENCES HOLDINGS CORPORATION

(IART)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/19/2021 10/20/2021 10/21/2021 10/22/2021 10/25/2021 Date
68.69(c) 69.81(c) 70.95(c) 70.82(c) 70.55 Last
278 280 220 471 287 651 325 339 211 821 Volume
+1.52% +1.63% +1.63% -0.18% -0.38% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 1 544 M - -
Net income 2021 157 M - -
Net Debt 2021 954 M - -
P/E ratio 2021 38,4x
Yield 2021 -
Sales 2022 1 641 M - -
Net income 2022 178 M - -
Net Debt 2022 620 M - -
P/E ratio 2022 34,1x
Yield 2022 -
Capitalization 5 967 M 5 967 M -
EV / Sales 2021 4,48x
EV / Sales 2022 4,01x
Nbr of Employees 3 700
Free-Float 81,2%
More Financials
Company
Integra LifeSciences Holdings Corporation provides regenerative technologies and neurosurgical solutions. The Company offers a portfolio of brands including AmnioExcel, Bactiseal, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, SurgiMend, TCC-EZ, and VersaTru. The Company offers solutions in orthopedics, neurosurgery, and reconstructive and general surgery. The... 
More about the company
Ratings of Integra LifeSciences Holdings Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about INTEGRA LIFESCIENCES HOLDINGS CORPORATION
10/06INTEGRA LIFESCIENCES : to Host Third Quarter 2021 Financial Results Conference Call on Nov..
AQ
09/15INTEGRA LIFESCIENCES : BTIG Downgrades Integra LifeSciences Holdings to Neutral from Buy
MT
09/07INSIDER SELL : Integra Lifesciences Holdings
MT
09/02INTEGRA LIFESCIENCES : Announces Participation in Upcoming Investor Conferences
AQ
08/10INSIDER TRENDS : 90-Day Insider Buying Trend at Integra LifeSciences Holdings Slowed with ..
MT
07/29INTEGRA LIFESCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
07/29Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan annou..
CI
07/28INTEGRA LIFESCIENCES : Q2 Adjusted Earnings, Revenue Rise; Issues Q3 Guidance, Updates Ful..
MT
07/28INTEGRA LIFESCIENCES : Reports Second Quarter 2021 Financial Results Raises Full-Year 2021..
PU
07/28INTEGRA LIFESCIENCES HOLDINGS CORP : Results of Operations and Financial Condition, Financ..
AQ
07/28INTEGRA : Q2 Earnings Snapshot
AQ
07/28INTEGRA LIFESCIENCES : Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Rep..
MT
07/28INTEGRA LIFESCIENCES : Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Pos..
MT
07/28Integra LifeSciences Reports Second Quarter 2021 Financial Results
GL
07/28Integra Lifesciences Holdings Corporation Reports Earnings Results for the Second Quart..
CI
More news
News in other languages on INTEGRA LIFESCIENCES HOLDINGS CORPORATION
2017INTEGRA LIFESCIENCES : bringt Integra«SurgiMend(TM) PRS Meshed-Kollagenmatrix für Brustrek..
2017GNW-NEWS : Integra LifeSciences bringt Integra«SurgiMend(TM) PRS Meshed-Kollagenmatrix für..
2017INTEGRA LIFESCIENCES : lance Integra« SurgiMend(TM) PRS Meshed Collagen Matrix pour la rec..
2017Integra LifeSciences will Neurochirurgie-Geschäft von Johnson & Johnson kaufen
More news
Analyst Recommendations on INTEGRA LIFESCIENCES HOLDINGS CORPORATION
More recommendations
Chart INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Duration : Period :
Integra LifeSciences Holdings Corporation Technical Analysis Chart | IART | US4579852082 | MarketScreener
Technical analysis trends INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 70,55 $
Average target price 77,40 $
Spread / Average Target 9,71%
EPS Revisions
Managers and Directors
Peter J. Arduini President, Chief Executive Officer & Director
Carrie Anderson Chief Financial Officer, Treasurer & Executive VP
Stuart M. Essig Chairman
Kenneth E. Burhop Chief Scientific Officer & Vice President
William Compton Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
INTEGRA LIFESCIENCES HOLDINGS CORPORATION8.67%5 990
ABBOTT LABORATORIES15.61%224 651
MEDTRONIC PLC5.48%165 656
BECTON, DICKINSON AND COMPANY-1.52%70 962
HOYA CORPORATION20.25%56 316
DEXCOM, INC.53.72%54 815